Related Experiment Video
Updated: May 22, 2026

Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Improved blood glucose disposal and altered insulin secretion patterns in adenosine A(1) receptor knockout mice
Gary K Yang1, Bertil B Fredholm, Timothy J Kieffer
1Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract:
Type 2 diabetes mellitus (T2DM) is characterized by the inability of the pancreatic β-cells to secrete enough insulin to meet the demands of the body. Therefore, research of potential therapeutic approaches to treat T2DM has focused on increasing insulin output from β-cells or improving systemic sensitivity to circulating insulin. In this study, we examined the role of the A(1) receptor in glucose homeostasis with the use of A(1) receptor knockout mice (A(1)R(-/-)). A(1)R(-/-) mice exhibited superior glucose tolerance compared with wild-type controls. However, glucose-stimulated insulin release, insulin sensitivity, weight gain, and food intake were comparable between the two genotypes. Following a glucose challenge, plasma glucagon levels in wild-type controls decreased, but this was not observed in A(1)R(-/-) mice. In addition, pancreas perfusion with oscillatory glucose levels of 10-min intervals produced a regular pattern of pulsatile insulin release with a 10-min cycling period in wild-type controls and 5 min in A(1)R(-/-) mice. When the mice were fed a high-fat diet (HFD), both genotypes exhibited impaired glucose tolerance and insulin resistance. Increased insulin release was observed in HFD-fed mice in both genotypes, but increased glucagon release was observed only in HFD-fed A(1)R(-/-) mice. In addition, the regular patterns of insulin release following oscillatory glucose perfusion were abolished in HFD-fed mice in both genotypes. In conclusion, A(1) receptors in the pancreas are involved in regulating the temporal patterns of insulin release, which could have implications in the development of glucose intolerance seen in T2DM.
Insights
A(1) receptors influence pancreatic insulin release patterns, impacting glucose homeostasis. Disrupting these receptors may affect type 2 diabetes development and treatment strategies.
Area of Science:
- Endocrinology
- Metabolic Research
- Diabetes Pathophysiology
Background:
- Type 2 diabetes mellitus (T2DM) involves insufficient insulin secretion from pancreatic β-cells.
- Therapeutic strategies for T2DM aim to boost insulin output or enhance insulin sensitivity.
- The role of A(1) receptors in glucose regulation requires further investigation.
Purpose of the Study:
- To investigate the function of A(1) receptors in maintaining glucose homeostasis.
- To determine the impact of A(1) receptor deficiency on insulin secretion and glucose tolerance.
- To explore the role of A(1) receptors in diet-induced glucose intolerance.
Main Methods:
- Utilized A(1) receptor knockout mice (A(1)R(-/-)) and wild-type controls.
- Assessed glucose tolerance, insulin release, insulin sensitivity, weight gain, and food intake.
- Analyzed plasma glucagon levels and performed pancreas perfusion studies under varying glucose conditions and high-fat diet (HFD) feeding.
Main Results:
- A(1)R(-/-) mice showed improved glucose tolerance but similar insulin release and sensitivity compared to controls.
- A(1)R(-/-) mice lacked the typical decrease in plasma glucagon post-glucose challenge.
- Pancreas perfusion revealed altered insulin release patterns in A(1)R(-/-) mice, with abolished regularity under HFD conditions.
Conclusions:
- A(1) receptors are crucial for regulating the temporal dynamics of insulin release.
- Dysregulation of A(1) receptor-mediated insulin secretion patterns may contribute to T2DM pathogenesis.
- Targeting A(1) receptors could offer novel therapeutic avenues for managing glucose intolerance.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
